canakinumab 150 MG in 1 ML Injection

RxCUI: 1864324
RxNorm name: canakinumab 150 MG in 1 ML Injection
Display name: canakinumab 150 MG in 1 ML Injection
Full name: canakinumab 150 MG in 1 ML Injection
Term type: PSN
Status: DailyMed mapping
Updated: 2026-06-04 23:39:05

Purple Book Biologic Products#

BLA, Proprietary name, Proper name table
BLA	Proprietary name	Proper name	License type	Status	Latest source
125319	Ilaris	canakinumab	351(a)	Disc	2026-06-01

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
Ilaris	CANAKINUMAB	Novartis Pharmaceuticals Corporation	7d271f3b-e4f9-4d80-8dcf-28d49123f80e	2026-06-08	Warnings, Adverse reactions	Exact identifier rxcui: 1864324

DailyMed RxNorm Mappings#

Set ID, RxNorm string, TTY table
Set ID	RxNorm string	TTY	SPL version	Label	Effective
7d271f3b-e4f9-4d80-8dcf-28d49123f80e	canakinumab 150 MG in 1 ML Injection	PSN	30	These highlights do not include all the information needed to use ILARIS safely and effectively. See full prescribing information for ILARIS. ILARIS ® (canakinumab) injection, for subcutaneous use Initial U.S. Approval: 2009	20250618
7d271f3b-e4f9-4d80-8dcf-28d49123f80e	1 ML canakinumab 150 MG/ML Injection	SCD	30	These highlights do not include all the information needed to use ILARIS safely and effectively. See full prescribing information for ILARIS. ILARIS ® (canakinumab) injection, for subcutaneous use Initial U.S. Approval: 2009	20250618
7d271f3b-e4f9-4d80-8dcf-28d49123f80e	canakinumab 150 MG per 1 ML Injection	SY	30	These highlights do not include all the information needed to use ILARIS safely and effectively. See full prescribing information for ILARIS. ILARIS ® (canakinumab) injection, for subcutaneous use Initial U.S. Approval: 2009	20250618